LABRADOR IRON ORE ROYALTY CORPORATION - RIO TINTO RELEASES IOC PRODUCTION AND SALES INFORMATION Iron Investing
Mesoblast Acquires Chimeric Antigen Receptor Platform Technology for Precision-Enhanced Cell Products Iron Investing
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION Iron Investing
Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter Iron Investing
